Levels of TNF-α and Soluble TNF Receptors in Normal-Weight, Overweight and Obese Patients with Dilated Non-Ischemic Cardiomyopathy: Does Anti-TNF Therapy Still Have Potential to Be Used in Heart Failure Depending on BMI?

Background. We sought to measure the levels of adipokines, TNF-α and soluble receptors (sTNFr1, sTNFr2) in heart failure patients with reduced ejection fraction (HFrEF) due to non-ischemic cardiomyopathy (nDCM). Methods. A total of 123 patients with HFrEF due to nDCM were divided into three groups a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazar-Poloczek, Elżbieta, Romuk, Ewa, Jacheć, Wojciech, Stanek, Wiktoria, Stanek, Bartosz, Szołtysik, Monika, Techmański, Tomasz, Hasterok, Maja, Wojciechowska, Celina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687112/
https://www.ncbi.nlm.nih.gov/pubmed/36428528
http://dx.doi.org/10.3390/biomedicines10112959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687112/
https://www.ncbi.nlm.nih.gov/pubmed/36428528
http://dx.doi.org/10.3390/biomedicines10112959

Ejemplares similares